Status | Study |
Recruiting |
Study Name: Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic Cancer Condition: Pancreatic Cancer Date: 2016-08-10 Interventions: Biological: Theragene®,Ad5-yCD/mutTKSR39rep-ADP Theragene®,Ad5-yCD/mutTKSR39rep-ADP is Adenovi |
Completed |
Study Name: Clinical Grade Adenovirus Specific T Cells for Immunotherapy After Allogeneic Stem Cell Transplantation (CTL-ADV) Condition: Adenovirus Infection Date: 2016-07-28 Interventions: Other: Infusion of ADV specific T cells Cell engineering |
Recruiting |
Study Name: A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer Condition: Prostate Cancer Date: 2016-07-14 Interventions: Drug: Mobilan (M-VM3) Mobilan |
Recruiting |
Study Name: A Randomised Phase II Open-label Study With a Phase Ib Safety lead-in Cohort of ONCOS-102, an Immune-priming GM-CSF Coding Oncolytic Adenovirus, and Pemetrexed/Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma Condition: To Determine Safety, Tolerability and Efficacy of ONCOS-102 in Combination With Chemotherapy Date: 2016-07-13 Interventions: Biological: ONCOS-102 Drug: Pemetrexed/cis |
Not yet recruiting |
Study Name: Ad-HGF Treatment for Myocardial Infarction Condition: Myocardial Infarction Date: 2016-06-29 Interventions: Drug: Ad-HGF Other: 0.9% NaCl |
Recruiting |
Study Name: Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects Condition: Brain Cancer Brain Neoplasm Glioma Date: 2016-06-09 Interventions: Biological: DNX-2401 On Day 0, |
Recruiting |
Study Name: Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation Condition: CMV Infection EBV Adenovirus Date: 2016-05-18 Interventions: Biological: Virus specific CTLs Virus specific CTLs will be given to patients with persistent or recurre |
Active, not recruiting |
Study Name: Study to Evaluate the Safety and Immunogenicity of Orally-administered HIV Vaccine in Healthy, HIV-uninfected Adult Participants Condition: Healthy Volunteer HIV Vaccine Date: 2016-05-05 Interventions: Biological: Ad4-mgag A live re |
Recruiting |
Study Name: Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine Condition: Acquired Immunodeficiency Syndrome Date: 2016-05-02 Interventions: Biological: Ad5-gag Ad5-gag is |
Recruiting |
Study Name: Study of Recombinant Adenovirus AdVince in Patients With Neuroendocrine Tumors; Safety and Efficacy Condition: Neuroendocrine Tumors Date: 2016-03-11 Interventions: Drug: AdVince Virus solution for infusion in intrahepatic artery |